Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial.

Trials 2017 05 22;18(1):228. Epub 2017 May 22.

Department of Clinical Psychology, Amsterdam Public Health Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Background: Cancer survivors have to deal with a wide range of physical symptoms, psychological, social and existential concerns, and lifestyle issues related to cancer and its treatment. Therefore, it is essential that they have access to optimal supportive care services. The eHealth self-management application Oncokompas was developed to support cancer survivors with where they need to turn to for advice and guidance, as well as to increase their knowledge on the availability of optimal support. A randomised controlled trial will be conducted to assess the efficacy, cost-utility and reach of Oncokompas as an eHealth self-management application compared with care as usual among cancer survivors.

Methods/design: Adult cancer survivors diagnosed with breast, colorectal or head and neck cancer or lymphoma who are at 3 months to 5 years since curative treatment will be included. In total, 544 cancer survivors will be randomly assigned to the intervention group or a wait-list control group. The primary outcome measure is patient activation. Secondary outcome measures include self-efficacy, personal control, perceived patient-physician interaction, need for supportive care, mental adjustment to cancer and health-related quality of life. Furthermore, cost-utility outcomes will be assessed. Reach is defined as the percentage of cancer survivors who get access to Oncokompas within the context of this trial. Questionnaires will be administered at baseline, post-intervention and at 3- and 6-month follow-up.

Discussion: In this study, we will evaluate the efficacy and cost-utility of Oncokompas among cancer survivors, as well as the reach of Oncokompas. These are essential first steps in the translation of research into practice and contribute to sustainable adoption, implementation and maintenance of an evidence-based Oncokompas.

Trial Registration: Netherlands Trial Register identifier: NTR5774 . Registered on 8 March 2016.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-017-1952-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440906PMC
May 2017
29 Reads

Publication Analysis

Top Keywords

cancer survivors
28
self-management application
12
ehealth self-management
12
supportive care
12
efficacy cost-utility
12
cancer
11
controlled trial
8
reach oncokompas
8
cost-utility reach
8
optimal supportive
8
randomised controlled
8
survivors
7
will
6
oncokompas
5
treatment will
4
will included
4
curative treatment
4
well reach
4
oncokompas essential
4
intervention group
4

References

(Supplied by CrossRef)

NK Aaronson et al.
EJC Suppl 2014

MI Fitch et al.
Can Oncol Nurs J 2008

RM Speck et al.
J Cancer Surviv 2010

SL Hart et al.
J Natl Cancer Inst 2012

JC Mewes et al.
Oncologist 2012

AW Boyes et al.
BMC Cancer 2012

JD Harrison et al.
Support Care Cancer 2009

F Jansen et al.
Support Care Cancer 2014

B Cimprich et al.
Psychooncology 2005

R McCorkle et al.
CA Cancer J Clin 2011

Similar Publications